Jump to main content
Jump to site search


An on-flow assay for screening of β-secretase ligands by immobilised capillary reactor-mass spectrometry

Author affiliations

Abstract

The enzyme β-secretase1 (BACE1) is an aspartyl protease that initiates the cleavage of the Aβ amyloid precursor protein (APP), to generate and aggregate β-amyloid (Aβ) peptides. Aggregates of Aβ peptides are implicated in the pathogenesis of Alzheimer's disease (AD), so inhibition of BACE1 is an attractive therapeutic strategy to treat AD. Many methods involving the principle of fluorescence resonance energy transfer (FRET) have been developed to evaluate the inhibitory activity of different compounds against enzymes. Because these methods have several drawbacks, studies involving mass spectrometry (MS) detection have been carried out. In this study, we prepared a BACE1 immobilised capillary enzyme reactor (ICER) attached to a mass spectrometer for the on-flow screening of ligands. First, we immobilised BACE1 on a fused silica capillary (BACE1-ICER, 30 cm × 0.1 mm ID) using glutaraldehyde as a spacer. We then used JMV2236, a peptide that mimics the Swedish mutated APP (amyloid protein precursor) sequence, as the substrate to characterise BACE1-ICER. Finally, we validated the method and investigated the kinetic parameter (KMap). We established the best conditions to accomplish coupling and inhibition studies by liquid chromatography-ion trap-mass spectrometry (LC-IT-MS) (inhibitory potency and mechanism of action) of the standard β-secretase inhibitor. The BACE1-ICER-MS method was reproducible and stable. The parameter KMap was 17.2 ± 5 μmol L−1, which demonstrated that immobilisation did not significantly change the structure, flexibility, or conformation of BACE1 or even the accessibility to the binding sites in the enzyme. IC50 and Ki were 1.19 ± 0.2 μmol L−1 and 0.96 ± 0.01 μmol L−1 for the standard β-secretase inhibitor, respectively, which confirmed that BACE1-ICER identifies the reference inhibitor at the micromole scale. BACE1-ICER remained active and stable along the development of the method and of the studies conducted herein and maintained 43% of residual activity after being used for ten months.

Graphical abstract: An on-flow assay for screening of β-secretase ligands by immobilised capillary reactor-mass spectrometry

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 31 Jan 2017, accepted on 09 Mar 2017, published on 10 Mar 2017 and first published online on 10 Mar 2017


Article type: Paper
DOI: 10.1039/C7AY00284J
Citation: Anal. Methods, 2017, Advance Article
  •   Request permissions

    An on-flow assay for screening of β-secretase ligands by immobilised capillary reactor-mass spectrometry

    A. Ferreira Lopes Vilela and C. L. Cardoso, Anal. Methods, 2017, Advance Article , DOI: 10.1039/C7AY00284J

Search articles by author